78 related articles for article (PubMed ID: 7343170)
1. Seventeen year survival in a patient with malignant peritoneal mesothelioma.
Brenner J; Sordillo PP; Magill GB
Clin Oncol; 1981 Sep; 7(3):249-51. PubMed ID: 7343170
[No Abstract] [Full Text] [Related]
2. Prognostic analysis of clinicopathologic factors in 49 patients with diffuse malignant peritoneal mesothelioma treated with cytoreductive surgery and intraperitoneal hyperthermic perfusion.
Deraco M; Nonaka D; Baratti D; Casali P; Rosai J; Younan R; Salvatore A; Cabras Ad AD; Kusamura S
Ann Surg Oncol; 2006 Feb; 13(2):229-37. PubMed ID: 16444562
[TBL] [Abstract][Full Text] [Related]
3. [Peritoneal mesothelioma. A case report].
Catania V; Bonaccorso R; Fraggetta F; Vecchio S; Grasso F; Cammisuli F; Minutolo V; Cavallaro V
Ann Ital Chir; 1996; 67(5):697-701. PubMed ID: 9036830
[TBL] [Abstract][Full Text] [Related]
4. Local-regional approach to diffuse malignant peritoneal mesothelioma.
Sugarbaker PH
Gastroenterol Clin Biol; 2007 Oct; 31(10):780-1. PubMed ID: 18166852
[No Abstract] [Full Text] [Related]
5. An Italian Multicentric Phase II study on peritonectomy and intra peritoneal hyperthermic perfusion (IPHP) to treat patients with peritoneal mesothelioma.
Deraco M; De Simone M; Rossi CR; Cavaliere F; Difilippo F; Scuderi S; Pilatti P; Kusamura S
J Exp Clin Cancer Res; 2003 Dec; 22(4 Suppl):41-5. PubMed ID: 16767905
[TBL] [Abstract][Full Text] [Related]
6. Impact of lymph node metastasis on outcome after extrapleural pneumonectomy for malignant pleural mesothelioma.
de Perrot M; Uy K; Anraku M; Tsao MS; Darling G; Waddell TK; Pierre AF; Bezjak A; Keshavjee S; Johnston MR
J Thorac Cardiovasc Surg; 2007 Jan; 133(1):111-6. PubMed ID: 17198794
[TBL] [Abstract][Full Text] [Related]
7. Sex difference in diffuse malignant peritoneal mesothelioma.
Yan TD; Popa E; Brun EA; Cerruto CA; Sugarbaker PH
Br J Surg; 2006 Dec; 93(12):1536-42. PubMed ID: 17048277
[TBL] [Abstract][Full Text] [Related]
8. Peritonectomy combined with intraperitoneal chemohyperthermia in abdominal cancer with peritoneal carcinomatosis: phase I-II study.
Gilly FN; Beaujard A; Glehen O; Grandclement E; Caillot JL; Francois Y; Sadeghi-Looyeh B; Gueugniaud PY; Garbit F; Benoit M; Bienvenu J; Vignal J
Anticancer Res; 1999; 19(3B):2317-21. PubMed ID: 10472351
[TBL] [Abstract][Full Text] [Related]
9. Diffuse malignant peritoneal mesothelioma: Failure analysis following cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC).
Baratti D; Kusamura S; Cabras AD; Dileo P; Laterza B; Deraco M
Ann Surg Oncol; 2009 Feb; 16(2):463-72. PubMed ID: 19082859
[TBL] [Abstract][Full Text] [Related]
10. Diffuse malignant mesothelioma of the peritoneum: a clinicopathological study of 35 patients treated locoregionally at a single institution.
Nonaka D; Kusamura S; Baratti D; Casali P; Cabras AD; Younan R; Rosai J; Deraco M
Cancer; 2005 Nov; 104(10):2181-8. PubMed ID: 16206294
[TBL] [Abstract][Full Text] [Related]
11. Peritoneal mesothelioma proposal for a staging system.
Sebbag G; Sugarbaker PH
Eur J Surg Oncol; 2001 Apr; 27(3):223-4. PubMed ID: 11373096
[No Abstract] [Full Text] [Related]
12. Multicystic and well-differentiated papillary peritoneal mesothelioma treated by surgical cytoreduction and hyperthermic intra-peritoneal chemotherapy (HIPEC).
Baratti D; Kusamura S; Nonaka D; Oliva GD; Laterza B; Deraco M
Ann Surg Oncol; 2007 Oct; 14(10):2790-7. PubMed ID: 17661150
[TBL] [Abstract][Full Text] [Related]
13. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival in selected patients with peritoneal carcinomatosis from abdominal and pelvic malignancies: results of 21 cases.
Yang XJ; Li Y; al-shammaa Hassan AH; Yang GL; Liu SY; Lu YL; Zhang JW; Yonemura Y
Ann Surg Oncol; 2009 Feb; 16(2):345-51. PubMed ID: 19018599
[TBL] [Abstract][Full Text] [Related]
14. [Prolonged survival in peritoneal mesotheliomas. Apropos of a case].
Berthet B; Guieu C; Blanc AP; Palayodan A; Chamlian A; Assadourian R
Ann Chir; 1995; 49(1):76-7. PubMed ID: 7741473
[TBL] [Abstract][Full Text] [Related]
15. Early peritoneal mesothelioma: a treatable malignancy.
Antman KH; Osteen RT; Klegar KL; Amato DA; Pomfret EA; Larson DA; Corson JM
Lancet; 1985 Nov; 2(8462):977-81. PubMed ID: 2414612
[TBL] [Abstract][Full Text] [Related]
16. [Updated treatment of peritoneal carcinomas: a review].
Deraco M; Laterza B; Kusamura S; Baratti D
Minerva Chir; 2007 Dec; 62(6):459-76. PubMed ID: 18091656
[TBL] [Abstract][Full Text] [Related]
17. [Recurrent benign cystic peritoneal mesothelioma].
Stroescu C; Negulescu R; Herlea V; David L; Ivanov B; Nitipir C; Popescu I
Chirurgia (Bucur); 2008; 103(6):715-8. PubMed ID: 19274921
[TBL] [Abstract][Full Text] [Related]
18. P16 loss and mitotic activity predict poor survival in patients with peritoneal malignant mesothelioma.
Borczuk AC; Taub RN; Hesdorffer M; Hibshoosh H; Chabot JA; Keohan ML; Alsberry R; Alexis D; Powell CA
Clin Cancer Res; 2005 May; 11(9):3303-8. PubMed ID: 15867227
[TBL] [Abstract][Full Text] [Related]
19. Prognostic indicators for patients undergoing cytoreductive surgery and perioperative intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma.
Yan TD; Brun EA; Cerruto CA; Haveric N; Chang D; Sugarbaker PH
Ann Surg Oncol; 2007 Jan; 14(1):41-9. PubMed ID: 17039392
[TBL] [Abstract][Full Text] [Related]
20. Malignant transformation of "benign" cystic mesothelioma of the peritoneum.
González-Moreno S; Yan H; Alcorn KW; Sugarbaker PH
J Surg Oncol; 2002 Apr; 79(4):243-51. PubMed ID: 11920782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
